Raquel Vayas1,2, Ricardo Reyes3,4, María Rosa Arnau5, Carmen Évora1,3, Araceli Delgado1,3. 1. Department of Chemical Engineering and Pharmaceutical Technology, Universidad de La Laguna, La Laguna, Spain. 2. Servicio de Cirugía Ortopédica y Traumatología, Complejo Hospitalario Universitario Ntra, Sra. de Candelaria, Santa Cruz de Tenerife, Spain. 3. Institute of Biomedical Technologies, Center for Biomedical Research of the Canary Islands, Universidad de La Laguna, La Laguna, Spain. 4. Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, La Laguna, Spain. 5. Servicio de Estabulario y Animalario del Servicio General de Apoyo a la Investigación, Universidad de La Laguna, La Laguna, Spain.
Abstract
OBJECTIVE: The limits of the microfracture (MFX) treatment in terms of lesion size and long-term tissue functionality makes it necessary to investigate different alternatives to repair focal cartilage lesions. The present study aims at evaluating the efficacy of a minimally invasive approach against the conventional MFX to repair a chondral defect in rabbits. An injectable scaffold of BMP-2 pre-encapsulated in PLGA microspheres dispersed in a Pluronic F-127 solution is proposed as support of cells and controlled delivery system for the growth factor. DESIGN: MFX was compared versus the injectable system seeded with mesenchymal stem cells (MSCs), both without BMP-2 and under controlled release of BMP-2 at 2 different doses (3 and 12 µg/scaffold). The different treatments were evaluated on a 4-mm diameter chondral defect model using 9 experimental groups of 4 rabbits (8 knees) each, throughout 24 weeks. RESULTS: Histologically, all the treated groups, except MFX treated, responded significantly better than the control group (nontreated defect). Although no significant differences were found between the treated groups, only BMP(12), MSC-BMP(12), and MFX-BMP(3) groups showed nonsignificant differences when compared with the normal cartilage. CONCLUSIONS: The hydrogel system proposed to control the release rate of the BMP-2 was safe, easily injectable, and also provided good support for cells. Treatments with MSCs or BMP-2 repaired efficiently the chondral lesion created in rabbits, being less invasive than MFX treatment.
OBJECTIVE: The limits of the microfracture (MFX) treatment in terms of lesion size and long-term tissue functionality makes it necessary to investigate different alternatives to repair focal cartilage lesions. The present study aims at evaluating the efficacy of a minimally invasive approach against the conventional MFX to repair a chondral defect in rabbits. An injectable scaffold of BMP-2 pre-encapsulated in PLGA microspheres dispersed in a Pluronic F-127 solution is proposed as support of cells and controlled delivery system for the growth factor. DESIGN: MFX was compared versus the injectable system seeded with mesenchymal stem cells (MSCs), both without BMP-2 and under controlled release of BMP-2 at 2 different doses (3 and 12 µg/scaffold). The different treatments were evaluated on a 4-mm diameter chondral defect model using 9 experimental groups of 4 rabbits (8 knees) each, throughout 24 weeks. RESULTS: Histologically, all the treated groups, except MFX treated, responded significantly better than the control group (nontreated defect). Although no significant differences were found between the treated groups, only BMP(12), MSC-BMP(12), and MFX-BMP(3) groups showed nonsignificant differences when compared with the normal cartilage. CONCLUSIONS: The hydrogel system proposed to control the release rate of the BMP-2 was safe, easily injectable, and also provided good support for cells. Treatments with MSCs or BMP-2 repaired efficiently the chondral lesion created in rabbits, being less invasive than MFX treatment.
Authors: Mats Brittberg; Lars Peterson; Eva Sjögren-Jansson; Tommi Tallheden; Anders Lindahl Journal: J Bone Joint Surg Am Date: 2003 Impact factor: 5.284
Authors: P C Kreuz; M R Steinwachs; C Erggelet; S J Krause; G Konrad; M Uhl; N Südkamp Journal: Osteoarthritis Cartilage Date: 2006-07-11 Impact factor: 6.576
Authors: M Rodríguez-Évora; A Delgado; R Reyes; A Hernández-Daranas; I Soriano; J San Román; C Evora Journal: Eur J Pharm Sci Date: 2013-06-21 Impact factor: 4.384
Authors: Lisa A Fortier; Joseph U Barker; Eric J Strauss; Taralyn M McCarrel; Brian J Cole Journal: Clin Orthop Relat Res Date: 2011-10 Impact factor: 4.176
Authors: Seth K Williams; David Amiel; Scott T Ball; R Todd Allen; Van W Wong; Albert C Chen; Robert L Sah; William D Bugbee Journal: J Bone Joint Surg Am Date: 2003-11 Impact factor: 5.284
Authors: Jason D Gibson; Michael B O'Sullivan; Farhang Alaee; David N Paglia; Ryu Yoshida; Rosa M Guzzo; Hicham Drissi Journal: Stem Cells Transl Med Date: 2016-08-05 Impact factor: 6.940